Patent · US Active

Pyrazolopyrimidine compounds and methods of use thereof

US11155557B2 · kind B2 · utility

1Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 25, 2019
Grant dateOct 26, 2021
Priority date—
Expiry dateJun 25, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of Formula (IA), or a pharmaceutically acceptable salt thereof, and methods of use as Janus kinase inhibitors are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.